iRadimed Corporation (NASDAQ:IRMD - Get Free Report) has earned an average rating of "Moderate Buy" from the six brokerages that are covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a stro